Publications:

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: ALK: 2387G>C; G796A

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 2

View BVdb publication page

Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer.

Cell Chemical Biology

Kaserer, Teresa T; Blagg, Julian J

Publication Date: 2018-11-15

Variant appearance in text: ALK: G796A

PubMed Link: 30146241

Variant Present in the following documents:

• Main text
• mmc9.pdf
• main.pdf

View BVdb publication page

Characterization of DNA variants in the human kinome in breast cancer.

Scientific Reports

Agarwal, Divyansh D; Qi, Yuan Y; Jiang, Tingting T; Liu, Xiuping X; Shi, Weiwei W; Wali, Vikram B VB; Turk, Benjamin B; Ross, Jeffrey S JS; Fraser Symmans, W W; Pusztai, Lajos L; Hatzis, Christos C

Publication Date: 2015-09-30

Variant appearance in text: ALK: G796A

PubMed Link: 26420498

Variant Present in the following documents:

• srep14736-s2.xls, sheet 53
• srep14736-s3.xls, sheet 1

View BVdb publication page